After rollout under emergency authorisation, manufacturers of covid-19 vaccines now have their sights on regulatory approval. But what’s the rush, asks Peter Doshi, and is just six months of data from now unblinded trials acceptable?http://ow.ly/at2D50F2Mqn
-
-
-
Replying to @Milesdominic @bmj_latest
Way ahead of you. I wrote about this two weeks ago.https://respectfulinsolence.com/2021/05/21/why-is-peter-doshi-still-an-editor-at-the-bmj-rfk-jr-version/ …
3 replies 5 retweets 15 likes -
Replying to @Milesdominic @bmj_latest
Pro tip: Search @ScienceBasedMed and @oracknows blogs before asking.
3:59 AM - 4 Jun 2021
0 replies
0 retweets
1 like
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.